Shareholder alert: pomerantz law firm investigates claims on behalf of investors of regeneron pharmaceuticals, inc. - regn

New york, june 22, 2024 (globe newswire) -- pomerantz llp is investigating claims on behalf of investors of regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn).   such investors are advised to contact danielle peyton at newaction@pomlaw.com  or 646-581-9980, ext. 7980.
REGN Ratings Summary
REGN Quant Ranking